PAPER Gioia M, De Bernardo M, Rosa N, Capasso L

Comment on: Choroidal Structural Analysis in Alzheimer Disease, Mild Cognitive Impairment, and Cognitively Healthy Controls.

Am J Ophthalmol. 2021 Jan 11; PubMed: 33444634

PAPER Robbins CB, Grewal DS, Thompson AC, Powers JH, Soundararajan S, Koo HY, Yoon SP, Polascik BW, Liu AJ, Agrawal R, Fekrat S

Reply to: "Comment on Choroidal Structural Analysis in Alzheimer Disease, Mild Cognitive Impairment, and Cognitively Healthy Controls".

Am J Ophthalmol. 2021 Jan 11; PubMed: 33444633

PAPER Urbanc B

Cross-Linked Amyloid β-Protein Oligomers: A Missing Link in Alzheimer's Disease Pathology?

J Phys Chem B. 2021 Feb 11;125(5):1307-1316. Epub 2021 Jan 13 PubMed: 33440940

PAPER Thanprasertsuk S, Likitjaroen Y

Pattern of cortical thinning in logopenic progressive aphasia patients in Thailand.

BMC Neurol. 2021 Jan 13;21(1):22. PubMed: 33441094

PAPER Govindarajulu M, Ramesh S, Neel L, Fabbrini M, Buabeid M, Fujihashi A, Dwyer D, Lynd T, Shah K, Mohanakumar KP, Smith F, Moore T, Dhanasekaran M

Nutraceutical based SIRT3 activators as therapeutic targets in Alzheimer's disease.

Neurochem Int. 2021 Mar;144:104958. Epub 2021 Jan 12 PubMed: 33444675

PAPER Bracko O, Cruz Hernández JC, Park L, Nishimura N, Schaffer CB

Causes and consequences of baseline cerebral blood flow reductions in Alzheimer's disease.

J Cereb Blood Flow Metab. 2021 Jan 14;:271678X20982383. PubMed: 33444096

PAPER Cummings J

New approaches to symptomatic treatments for Alzheimer's disease.

Mol Neurodegener. 2021 Jan 13;16(1):2. PubMed: 33441154

PAPER Beattie Z, Miller LM, Almirola C, Au-Yeung WM, Bernard H, Cosgrove KE, Dodge HH, Gamboa CJ, Golonka O, Gothard S, Harbison S, Irish S, Kornfeld J, Lee J, Marcoe J, Mattek NC, Quinn C, Reynolds C, Riley T, Rodrigues N, Sharma N, Siqueland MA, Thomas NW, Truty T, Wall R, Wild K, Wu CY, Karlawish J, Silverberg NB, Barnes LL, Czaja S, Silbert LC, Kaye J

The Collaborative Aging Research Using Technology Initiative: An Open, Sharable, Technology-Agnostic Platform for the Research Community.

Digit Biomark. 2020;4(Suppl 1):100-118. Epub 2020 Nov 26 PubMed: 33442584

PAPER Zanardi A, Alessio M

Ceruloplasmin Deamidation in Neurodegeneration: From Loss to Gain of Function.

Int J Mol Sci. 2021 Jan 11;22(2) PubMed: 33440850

PAPER Jones A, Morgan-Jones P, Busse M, Shepherd V, Wood F

Conducting focus groups in neurodegenerative disease populations: ethical and methodological considerations.

BMJ Open. 2021 Jan 13;11(1):e041869. PubMed: 33441358

PAPER Lattante S, Doronzio PN, Conte A, Marangi G, Martello F, Bisogni G, Meleo E, Colavito D, Del Giudice E, Patanella AK, Bernardo D, Romano A, Zollino M, Sabatelli M

Novel variants and cellular studies on patients' primary fibroblasts support a role for NEK1 missense variants in ALS pathogenesis.

Hum Mol Genet. 2021 Mar 25;30(1):65-71. PubMed: 33445179

PAPER Liguori C, Spanetta M, Romoli M, Placidi F, Nardi Cesarini E, Mercuri NB, Costa C

Sleep disorders and late-onset epilepsy of unknown origin: Understanding new trajectories to brain amyloidopathy.

Mech Ageing Dev. 2021 Mar;194:111434. Epub 2021 Jan 11 PubMed: 33444630

PAPER Daskalov A, Martinez D, Coustou V, El Mammeri N, Berbon M, Andreas LB, Bardiaux B, Stanek J, Noubhani A, Kauffmann B, Wall JS, Pintacuda G, Saupe SJ, Habenstein B, Loquet A

Structural and molecular basis of cross-seeding barriers in amyloids.

Proc Natl Acad Sci U S A. 2021 Jan 5;118(1) PubMed: 33443172

PAPER Apicco DJ, Shlevkov E, Nezich CL, Tran DT, Guilmette E, Nicholatos JW, Bantle CM, Chen Y, Glajch KE, Abraham NA, Dang LT, Kaynor GC, Tsai EA, Nguyen KH, Groot J, Liu Y, Weihofen A, Hurt JA, Runz H, Hirst WD

The Parkinson's disease-associated gene ITPKB protects against α-synuclein aggregation by regulating ER-to-mitochondria calcium release.

Proc Natl Acad Sci U S A. 2021 Jan 5;118(1) PubMed: 33443159

2022 Neurobiology of Brain Disorders Award

GRANT Friday, January 15, 2021- 15:30 The McKnight Endowment Fund for Neuroscience Up to four awards are made annually, each providing $100,000 per year for three years. LOIs are due on March 15, 2021 (midnight in the last time zone on earth). Full proposals ...